압박 요법 시장 : 제품별, 소재별, 기술별, 유통 채널별, 최종 사용자별, 용도별 - 세계 시장 예측(2026-2032년)

The Compression Therapy Market is projected to grow by USD 6.37 billion at a CAGR of 5.37% by 2032.

Compression Therapy Market Executive Summary

Compression therapy is a cornerstone of vascular, wound care, lymphatic, orthopedic, and post-surgical management, using graduated compression stockings, wraps, bandages, sleeves, and intermittent pneumatic compression devices to improve venous return, reduce edema, and support deep vein thrombosis prevention. Demand is supported by well-established clinical needs: the CDC estimates that venous thromboembolism affects up to 900,000 people annually in the United States, while the International Diabetes Federation reported 537 million adults living with diabetes in 2021, increasing the population at risk for lower-limb complications, venous ulcers, and chronic wounds.

The compression therapy market is also shaped by demographic change. The World Health Organization states that by 2030, 1 in 6 people globally will be aged 60 years or older, a major indicator for higher incidence of chronic venous insufficiency, lymphedema, immobility, and post-operative recovery needs. As healthcare systems prioritize prevention, faster discharge, and home-based care, compression therapy products are moving from hospital-only protocols into ambulatory clinics, retail pharmacies, rehabilitation centers, and digitally supported home care pathways.

Transformative Shifts in the Compression Therapy Landscape

The compression therapy landscape is shifting from basic elastic garments toward clinically differentiated, patient-specific, and digitally enabled solutions. Providers are increasingly selecting products based on pressure consistency, ease of application, skin safety, patient adherence, and compatibility with wound dressings or orthopedic recovery plans. This is particularly important for older adults and patients with limited mobility, where incorrect application can reduce clinical benefit or create safety concerns.

Reimbursement pressure and workforce shortages are accelerating adoption of easy-to-use wraps, adjustable compression systems, and portable pneumatic compression devices that support outpatient and home use. At the same time, sports medicine, wellness recovery, and post-surgical rehabilitation are expanding the addressable market beyond traditional venous disease treatment. Manufacturers that combine clinical evidence, comfort, durability, and lower total cost of care are positioned to strengthen competitiveness as healthcare purchasers demand measurable outcomes.

Cumulative Impact of Artificial Intelligence on Compression Therapy

Artificial intelligence is beginning to influence compression therapy through improved product selection, remote monitoring, inventory planning, and patient adherence analytics. AI-enabled image analysis can support wound measurement and edema tracking, while connected compression devices can help clinicians review usage patterns and identify patients who may not be following prescribed therapy. These tools are particularly relevant in chronic wound, lymphedema, and venous insufficiency management, where treatment success depends on sustained use over time.

The cumulative impact of AI is expected to be operational as much as clinical. Predictive analytics can help suppliers forecast stocking sizes, compression levels, replacement cycles, and device demand by geography and care setting. In manufacturing, AI-assisted quality control can improve consistency in textile tension, garment dimensions, pressure profiles, and device performance. However, adoption depends on regulatory compliance, data privacy safeguards, clinician trust, interoperability, and evidence that digital features improve outcomes rather than simply adding cost.

Key Regional Insights for Compression Therapy

In North America, compression therapy demand is supported by a large aging population, high rates of obesity, diabetes, and venous thromboembolism, and a mature ecosystem of hospitals, wound care centers, home health providers, rehabilitation facilities, and durable medical equipment suppliers. The United States remains a major demand center because of established vascular care pathways and strong adoption of advanced pneumatic compression and adjustable compression products, while Canada benefits from structured public healthcare access, chronic disease management programs, and expanding community-based care.

Europe represents a clinically sophisticated market, with Germany, France, Italy, Spain, and the United Kingdom showing strong use of compression stockings, bandaging systems, and wound care protocols. The region benefits from established venous and lymphatic disease guidelines, but pricing controls, medical device regulation, and procurement scrutiny push vendors to demonstrate cost-effectiveness and clinical value. Asia-Pacific is expanding as China, India, Japan, South Korea, Australia, and ASEAN healthcare systems address aging, diabetes, surgical recovery, sports rehabilitation, and rising awareness of venous disorders.

Latin America shows growing demand in Brazil and Mexico, where expanding private healthcare, diabetes burden, and vascular care access support market development, although affordability and reimbursement gaps remain barriers. The Middle East, especially GCC markets, is investing in specialty care, rehabilitation, and hospital infrastructure, creating opportunities for premium compression devices, post-surgical recovery products, and clinical education. Africa remains earlier in adoption, with demand concentrated in urban hospitals and private clinics, but long-term need is supported by diabetes growth, trauma care, maternal health, wound management, and improving access to essential medical supplies.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

Across ASEAN, compression therapy growth is linked to expanding hospital capacity, medical tourism, diabetes care, vascular care, and post-surgical rehabilitation, with demand strongest where private healthcare access and specialist wound care are improving. The GCC shows favorable conditions for advanced compression therapy because of high investment in tertiary care, rehabilitation services, chronic disease programs, and premium hospital infrastructure, while hot climates make breathable, lightweight, and comfortable product design especially important for adherence.

The European Union is a major evidence-driven market where medical device regulation, reimbursement controls, public procurement, and clinical guidelines influence product positioning. EU providers typically favor clinically validated compression levels, standardized sizing, clear labeling, and products that support wound care efficiency. BRICS countries represent a large-volume opportunity, led by China and India for population scale and diabetes burden, Brazil for private healthcare expansion, Russia for hospital-based demand, and South Africa as a regional access point for sub-Saharan care delivery.

G7 countries are leading adopters of premium compression technologies because they combine aging populations, established reimbursement structures, advanced surgical care, and high awareness of venous thromboembolism prevention. NATO member markets overlap significantly with North America and Europe, where military medicine, rehabilitation, trauma recovery, and mobility support can reinforce demand for compression systems used in vascular protection, edema control, post-injury recovery, and operational readiness.

Key Country Insights for Compression Therapy

The United States leads demand through advanced wound care networks, vascular surgery capacity, high awareness of deep vein thrombosis prevention, and broad use of home-based durable medical equipment. Canada shows steady adoption through public healthcare pathways, chronic disease management, and community care models, while Mexico and Brazil are gaining momentum as private hospitals, diabetes programs, obesity management, and vascular care services expand.

In Europe, the United Kingdom emphasizes guideline-based prevention, venous leg ulcer management, and community care efficiency; Germany has strong medical device adoption, structured reimbursement, and clinical discipline; France maintains a mature compression garment culture; Italy and Spain benefit from aging demographics, surgical recovery needs, and venous disease management; and Russia sustains demand through hospital and specialist care channels despite procurement complexity. These markets value clinically proven compression levels, durable materials, skin-friendly textiles, and products that reduce nursing time.

In Asia-Pacific, China offers scale through hospital modernization, aging, and diabetes prevalence, while India combines a large patient base with rising awareness of wound care, lymphedema management, and post-surgical recovery. Japan's super-aged population supports demand for comfortable, easy-to-apply compression products, and South Korea's advanced hospital system favors quality, innovation, and rehabilitation-focused solutions. Australia demonstrates strong adoption through sports medicine, rehabilitation, vascular care, home health channels, and evidence-based clinical practice.

Actionable Recommendations for Compression Therapy Leaders

Industry leaders should prioritize clinically validated products that improve adherence, reduce application errors, and support home-based care. Adjustable wraps, breathable compression garments, multilayer bandaging systems, and portable pneumatic compression devices should be designed around patient comfort, caregiver usability, skin safety, and measurable outcomes. Evidence generation is essential: claims should be supported by clinical studies, pressure performance testing, real-world adherence data, usability research, and health economic analysis.

Companies should also strengthen regional go-to-market models. In mature markets, differentiation should focus on outcomes, reimbursement support, digital monitoring, product training, and integration with wound care and vascular care pathways. In emerging markets, growth depends on affordability, clinician education, distributor reliability, and product portfolios that include both premium and value-based options. AI and connected care should be deployed selectively where they improve compliance, inventory planning, remote follow-up, documentation, or care coordination.

Research Methodology for Compression Therapy Market Analysis

This executive summary is developed using a structured secondary research approach based on verified public health, clinical, regulatory, and industry sources. Inputs include epidemiological indicators from organizations such as the World Health Organization, CDC, and International Diabetes Federation, along with established clinical understanding of venous thromboembolism, chronic venous insufficiency, lymphedema, diabetes-related complications, wound care, immobility, and post-operative recovery.

The analysis evaluates market demand drivers, care-setting shifts, regional healthcare infrastructure, reimbursement dynamics, technology adoption, product innovation, regulatory considerations, and patient adherence trends. Insights are synthesized to support strategic decision-making for manufacturers, distributors, investors, healthcare providers, and procurement teams operating in the compression therapy market. No unsupported market-size figures, market share claims, or forecasts are used; the emphasis is on data-backed disease burden, demographic trends, and observable healthcare adoption patterns.

Conclusion: Compression Therapy Outlook

Compression therapy is becoming more important as healthcare systems manage aging populations, diabetes-related complications, chronic venous disease, lymphedema, post-surgical recovery, and the shift toward outpatient and home-based care. The market is evolving from commodity compression garments to differentiated solutions that combine clinical performance, comfort, usability, skin protection, and digital support.

Future competitiveness will depend on evidence-based product design, patient adherence, regulatory quality, clinician education, and regional access strategies. Organizations that align compression therapy innovation with measurable outcomes, workflow efficiency, and affordability will be best positioned to capture demand across hospitals, wound care centers, rehabilitation settings, retail channels, sports recovery, and home care.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Compression Therapy Market, by Product

• 7.1. Compression Sleeves
• 7.2. Compression Stockings
  • 7.2.1. Circular Knit
  • 7.2.2. Flat Knit
• 7.3. Compression Wraps
• 7.4. Elastic Bandages
• 7.5. Intermittent Pneumatic Devices

8. Compression Therapy Market, by Material

• 8.1. Neoprene
• 8.2. Rubber
• 8.3. Textile

9. Compression Therapy Market, by Technology

• 9.1. Dynamic Compression Therapy
• 9.2. Static Compression Therapy

10. Compression Therapy Market, by Distribution Channel

• 10.1. Offline
• 10.2. Online

11. Compression Therapy Market, by End User

• 11.1. Clinics
• 11.2. Home Care
• 11.3. Hospitals
• 11.4. Specialty Centers

12. Compression Therapy Market, by Application

• 12.1. Deep Vein Thrombosis
• 12.2. Lymphedema
• 12.3. Post-Surgical Recovery
• 12.4. Sports & Orthopedic Therapy
• 12.5. Varicose Veins & Spider Veins
• 12.6. Venous Leg Ulcers

13. Compression Therapy Market, by Region

• 13.1. Asia-Pacific
• 13.2. North America
• 13.3. Latin America
• 13.4. Europe
• 13.5. Middle East
• 13.6. Africa

14. Compression Therapy Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Compression Therapy Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Concentration Analysis, 2025
  • 16.1.1. Concentration Ratio (CR)
  • 16.1.2. Herfindahl Hirschman Index (HHI)
• 16.2. Recent Developments & Impact Analysis, 2025
• 16.3. Product Portfolio Analysis, 2025
• 16.4. Benchmarking Analysis, 2025

17. Company Profiles

• 17.1. 3M Company
• 17.2. AIROS Medical, Inc.
• 17.3. Arjo
• 17.4. Bio Compression Systems, Inc.
• 17.5. Cardinal Health, Inc.
• 17.6. ConvaTec Group PLC
• 17.7. DJO, LLC by Enovis Corporation
• 17.8. Essity Aktiebolag
• 17.9. Julius Zorn GmbH
• 17.10. KOYA MEDICAL
• 17.11. L&R Group
• 17.12. medi GmbH & Co. KG
• 17.13. Medtronic PLC
• 17.14. Milliken & Company
• 17.15. Molnlycke Health Care AB
• 17.16. Paul Hartmann AG
• 17.17. Sanyleg SRL
• 17.18. Sigvaris Group
• 17.19. Smith & Nephew PLC
• 17.20. Tactile Systems Technology, Inc.
• 17.21. Thuasne SA
• 17.22. Zimmer Biomet Holdings, Inc.